PSME3 and retinal disorder: Indeed, studies in two mouse models have demonstrated that MFRP-retinopathy is a potential target for gene-based therapy: Mfrprd6/Mfrprd6 described by Dinculescu et al. 53 and Mfrp KI/KI described by Chekuri et al. 54.